| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.39 | 0.009 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.47 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |